Brian M. Stuglik

Companies

• Puma BiotechnologyBoard member Jul 7, 2020 to now¹
• Verastem OncologyBoard member Sep 8, 2017 to now²
• Verastem OncologyChief executive officer Jul 31, 2019 to Jun 21, 2023³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PBPuma Biotechnology PBYI113,858 shares⁴$1.2M at $10.68Jun 12, 2026
• Verastem Oncology VSTM137,147 shares⁵$1.2M at $8.77May 21, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 12, 2026Sold 8,100 shares at $7.20 of Puma Biotechnology⁴
• Jun 11, 2026Granted 27,000 shares of Puma Biotechnology⁴
• May 21, 2026Granted 36,000 shares of Verastem Oncology⁵
• Dec 16, 2025Sold 592 shares at $9.14 of Verastem Oncology⁶
• Sep 16, 2025Sold 587 shares at $9.99 of Verastem Oncology⁷
• Jun 16, 2025Sold 594 shares at $5.65 of Verastem Oncology⁸
• Jun 13, 2025Sold 8,100 shares at $3.39 of Puma Biotechnology⁹
• Jun 11, 2025Granted 27,000 shares of Puma Biotechnology¹⁰
• May 22, 2025Granted 8,333 shares of Verastem Oncology¹¹
• Mar 17, 2025Sold 593 shares at $6.95 of Verastem Oncology¹²
• Dec 19, 2024Sold 334 shares at $4.37 of Verastem Oncology¹³
• Dec 16, 2024Sold 595 shares at $4.54 of Verastem Oncology¹³
• Sep 19, 2024Sold 336 shares at $2.79 of Verastem Oncology¹⁴
• Sep 16, 2024Sold 600 shares at $2.80 of Verastem Oncology¹⁵
• Jun 20, 2024Sold 335 shares at $3.21 of Verastem Oncology¹⁶
• Jun 18, 2024Granted 8,333 shares of Verastem Oncology¹⁶
• Jun 18, 2024Granted 27,000 shares of Puma Biotechnology¹⁷
• Jun 17, 2024Sold 593 shares at $3.49 of Verastem Oncology¹⁶
• Jun 13, 2024Sold 9,900 shares at $3.39 of Puma Biotechnology¹⁸
• Mar 19, 2024Sold 273 shares at $10.38 of Verastem Oncology¹⁹
• Mar 18, 2024Sold 537 shares at $10.71 of Verastem Oncology¹⁹
• Dec 19, 2023Sold 274 shares at $7.73 of Verastem Oncology²⁰
• Dec 18, 2023Sold 487 shares at $7.64 of Verastem Oncology²⁰
• Sep 19, 2023Sold 274 shares at $9.84 of Verastem Oncology²¹
• Sep 18, 2023Sold 478 shares at $9.91 of Verastem Oncology²¹